Drug intelligence / Profile preview

Beconase Activ Syrup

Development stage: Unknown
Modality: Small Molecules

Overview

Beconase Activ Syrup (likely a misspelling or variant of Beconuts Activ Syrup) is a nutraceutical dietary supplement developed and marketed by IGP Mediventures. It is formulated as a Vitamin B-Complex syrup intended to support general metabolic health, energy production, and the prevention of nutritional deficiencies. The product contains a blend of essential B vitamins, which serve as vital cofactors for numerous enzymes involved in cellular respiration, DNA synthesis, and neurological function. As a consumer wellness product sold through e-commerce platforms, it is classified as an over-the-counter supplement rather than a pharmaceutical drug candidate in a clinical development pipeline.

Brand names: Beconase Activ SyrupBeconuts Activ Syrup
Other names: Beconuts Activ SyrupVitamin B-Complex Syrup

Beyond the preview

Go deeper on Beconase Activ Syrup.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beconase Activ Syrup.

Explore the full profile